Loading…
Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL
Haematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmribera@ns.hugtip.scs.es BACKGROUND AND OBJECTIVES: To evaluate the impact of early and delayed consolidation chemotherapy on the outcome of children with acute lymphoblastic leukemia (ALL) stratified according to...
Saved in:
| Published in: | Haematologica (Roma) 2001-06, Vol.86 (6), p.586-595 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 595 |
| container_issue | 6 |
| container_start_page | 586 |
| container_title | Haematologica (Roma) |
| container_volume | 86 |
| creator | Ortega, JJ Ribera, JM Oriol, A Bastida, P Gonzalez, ME Calvo, C Egurbide, I Hernandez Rivas, JM Rivas, C Alcala, A Besalduch, J Macia, J Gardella, S Carnero, M Lite, JM Casanova, F Martinez, M Fontanillas, M Feliu, E San Miguel, JF PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas |
| description | Haematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmribera@ns.hugtip.scs.es
BACKGROUND AND OBJECTIVES: To evaluate the impact of early and delayed consolidation chemotherapy on the outcome of children with acute lymphoblastic leukemia (ALL) stratified according to risk groups. DESIGN AND METHODS: From 1989 to 1994, 195 children ( |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70929086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70929086</sourcerecordid><originalsourceid>FETCH-LOGICAL-h266t-13e79735d89bce37a4aaff5e3a372a6f41aa06425f6944317dec40302746cfbd3</originalsourceid><addsrcrecordid>eNpFkdtu1DAQhiMEokvhFZAvgLsgx0ns-HJVbQ9SEAgt19GsM2mGOgdsp1F4S94IV13E1VjyN9_8Y79IdlmpRVopkb1MdjzXPJVcVRfJG-9_ci641up1cpFlRVblUu2SPwdwdmMwtqxFCxu2zEyjnyy1EGgamelxmEKPDuaNebofqSMDY4hNNMxuekTP4jWblmCmIdYutpBtHY5spdAzGgO6AVuCgMyRf2Bglni02zD308mCD2SYxeUBB4LP7JpGsMyhX2zwT7onexzkZzSBHqMjhp0G-h2jfjscbw9f9mxf12ml2fH73b5-m7zqwHp8d66XyY_rw_HqNq2_3txd7eu0F1KGNMtRaZWXbaVPBnMFBUDXlZhDrgTIrsgAuCxE2UldFHmmWjQFz7lQhTTdqc0vk0_P3pjt14I-NAN5g9bCiNPiG8W10LySEXx_BpdTfIdmdjSA25p_nxCBD2cAvAHbxQUN-f8cl6LgWcQ-PmM93fcrOWz8ANZGq2jWda1kI5syzvsLSIeisw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70929086</pqid></control><display><type>article</type><title>Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL</title><source>Freely Accessible Science Journals</source><creator>Ortega, JJ ; Ribera, JM ; Oriol, A ; Bastida, P ; Gonzalez, ME ; Calvo, C ; Egurbide, I ; Hernandez Rivas, JM ; Rivas, C ; Alcala, A ; Besalduch, J ; Macia, J ; Gardella, S ; Carnero, M ; Lite, JM ; Casanova, F ; Martinez, M ; Fontanillas, M ; Feliu, E ; San Miguel, JF ; PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</creator><creatorcontrib>Ortega, JJ ; Ribera, JM ; Oriol, A ; Bastida, P ; Gonzalez, ME ; Calvo, C ; Egurbide, I ; Hernandez Rivas, JM ; Rivas, C ; Alcala, A ; Besalduch, J ; Macia, J ; Gardella, S ; Carnero, M ; Lite, JM ; Casanova, F ; Martinez, M ; Fontanillas, M ; Feliu, E ; San Miguel, JF ; PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas ; PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas</creatorcontrib><description>Haematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmribera@ns.hugtip.scs.es
BACKGROUND AND OBJECTIVES: To evaluate the impact of early and delayed consolidation chemotherapy on the outcome of children with acute lymphoblastic leukemia (ALL) stratified according to risk groups. DESIGN AND METHODS: From 1989 to 1994, 195 children (</description><identifier>ISSN: 0390-6078</identifier><identifier>EISSN: 1592-8721</identifier><identifier>PMID: 11418367</identifier><language>eng</language><publisher>Pavia: Haematologica</publisher><subject>Antineoplastic agents ; Antineoplastic Combined Chemotherapy Protocols - administration & dosage ; Antineoplastic Combined Chemotherapy Protocols - standards ; Biological and medical sciences ; Chemotherapy ; Child ; Child, Preschool ; Drug Administration Schedule ; Female ; Humans ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy ; Prospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome</subject><ispartof>Haematologica (Roma), 2001-06, Vol.86 (6), p.586-595</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1062401$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11418367$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ortega, JJ</creatorcontrib><creatorcontrib>Ribera, JM</creatorcontrib><creatorcontrib>Oriol, A</creatorcontrib><creatorcontrib>Bastida, P</creatorcontrib><creatorcontrib>Gonzalez, ME</creatorcontrib><creatorcontrib>Calvo, C</creatorcontrib><creatorcontrib>Egurbide, I</creatorcontrib><creatorcontrib>Hernandez Rivas, JM</creatorcontrib><creatorcontrib>Rivas, C</creatorcontrib><creatorcontrib>Alcala, A</creatorcontrib><creatorcontrib>Besalduch, J</creatorcontrib><creatorcontrib>Macia, J</creatorcontrib><creatorcontrib>Gardella, S</creatorcontrib><creatorcontrib>Carnero, M</creatorcontrib><creatorcontrib>Lite, JM</creatorcontrib><creatorcontrib>Casanova, F</creatorcontrib><creatorcontrib>Martinez, M</creatorcontrib><creatorcontrib>Fontanillas, M</creatorcontrib><creatorcontrib>Feliu, E</creatorcontrib><creatorcontrib>San Miguel, JF</creatorcontrib><creatorcontrib>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</creatorcontrib><creatorcontrib>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas</creatorcontrib><title>Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL</title><title>Haematologica (Roma)</title><addtitle>Haematologica</addtitle><description>Haematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmribera@ns.hugtip.scs.es
BACKGROUND AND OBJECTIVES: To evaluate the impact of early and delayed consolidation chemotherapy on the outcome of children with acute lymphoblastic leukemia (ALL) stratified according to risk groups. DESIGN AND METHODS: From 1989 to 1994, 195 children (</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</subject><subject>Antineoplastic Combined Chemotherapy Protocols - standards</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0390-6078</issn><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpFkdtu1DAQhiMEokvhFZAvgLsgx0ns-HJVbQ9SEAgt19GsM2mGOgdsp1F4S94IV13E1VjyN9_8Y79IdlmpRVopkb1MdjzXPJVcVRfJG-9_ci641up1cpFlRVblUu2SPwdwdmMwtqxFCxu2zEyjnyy1EGgamelxmEKPDuaNebofqSMDY4hNNMxuekTP4jWblmCmIdYutpBtHY5spdAzGgO6AVuCgMyRf2Bglni02zD308mCD2SYxeUBB4LP7JpGsMyhX2zwT7onexzkZzSBHqMjhp0G-h2jfjscbw9f9mxf12ml2fH73b5-m7zqwHp8d66XyY_rw_HqNq2_3txd7eu0F1KGNMtRaZWXbaVPBnMFBUDXlZhDrgTIrsgAuCxE2UldFHmmWjQFz7lQhTTdqc0vk0_P3pjt14I-NAN5g9bCiNPiG8W10LySEXx_BpdTfIdmdjSA25p_nxCBD2cAvAHbxQUN-f8cl6LgWcQ-PmM93fcrOWz8ANZGq2jWda1kI5syzvsLSIeisw</recordid><startdate>20010601</startdate><enddate>20010601</enddate><creator>Ortega, JJ</creator><creator>Ribera, JM</creator><creator>Oriol, A</creator><creator>Bastida, P</creator><creator>Gonzalez, ME</creator><creator>Calvo, C</creator><creator>Egurbide, I</creator><creator>Hernandez Rivas, JM</creator><creator>Rivas, C</creator><creator>Alcala, A</creator><creator>Besalduch, J</creator><creator>Macia, J</creator><creator>Gardella, S</creator><creator>Carnero, M</creator><creator>Lite, JM</creator><creator>Casanova, F</creator><creator>Martinez, M</creator><creator>Fontanillas, M</creator><creator>Feliu, E</creator><creator>San Miguel, JF</creator><creator>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</creator><general>Haematologica</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20010601</creationdate><title>Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL</title><author>Ortega, JJ ; Ribera, JM ; Oriol, A ; Bastida, P ; Gonzalez, ME ; Calvo, C ; Egurbide, I ; Hernandez Rivas, JM ; Rivas, C ; Alcala, A ; Besalduch, J ; Macia, J ; Gardella, S ; Carnero, M ; Lite, JM ; Casanova, F ; Martinez, M ; Fontanillas, M ; Feliu, E ; San Miguel, JF ; PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h266t-13e79735d89bce37a4aaff5e3a372a6f41aa06425f6944317dec40302746cfbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Combined Chemotherapy Protocols - administration & dosage</topic><topic>Antineoplastic Combined Chemotherapy Protocols - standards</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ortega, JJ</creatorcontrib><creatorcontrib>Ribera, JM</creatorcontrib><creatorcontrib>Oriol, A</creatorcontrib><creatorcontrib>Bastida, P</creatorcontrib><creatorcontrib>Gonzalez, ME</creatorcontrib><creatorcontrib>Calvo, C</creatorcontrib><creatorcontrib>Egurbide, I</creatorcontrib><creatorcontrib>Hernandez Rivas, JM</creatorcontrib><creatorcontrib>Rivas, C</creatorcontrib><creatorcontrib>Alcala, A</creatorcontrib><creatorcontrib>Besalduch, J</creatorcontrib><creatorcontrib>Macia, J</creatorcontrib><creatorcontrib>Gardella, S</creatorcontrib><creatorcontrib>Carnero, M</creatorcontrib><creatorcontrib>Lite, JM</creatorcontrib><creatorcontrib>Casanova, F</creatorcontrib><creatorcontrib>Martinez, M</creatorcontrib><creatorcontrib>Fontanillas, M</creatorcontrib><creatorcontrib>Feliu, E</creatorcontrib><creatorcontrib>San Miguel, JF</creatorcontrib><creatorcontrib>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</creatorcontrib><creatorcontrib>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ortega, JJ</au><au>Ribera, JM</au><au>Oriol, A</au><au>Bastida, P</au><au>Gonzalez, ME</au><au>Calvo, C</au><au>Egurbide, I</au><au>Hernandez Rivas, JM</au><au>Rivas, C</au><au>Alcala, A</au><au>Besalduch, J</au><au>Macia, J</au><au>Gardella, S</au><au>Carnero, M</au><au>Lite, JM</au><au>Casanova, F</au><au>Martinez, M</au><au>Fontanillas, M</au><au>Feliu, E</au><au>San Miguel, JF</au><au>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatias Malignas</au><aucorp>PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL</atitle><jtitle>Haematologica (Roma)</jtitle><addtitle>Haematologica</addtitle><date>2001-06-01</date><risdate>2001</risdate><volume>86</volume><issue>6</issue><spage>586</spage><epage>595</epage><pages>586-595</pages><issn>0390-6078</issn><eissn>1592-8721</eissn><abstract>Haematology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. jmribera@ns.hugtip.scs.es
BACKGROUND AND OBJECTIVES: To evaluate the impact of early and delayed consolidation chemotherapy on the outcome of children with acute lymphoblastic leukemia (ALL) stratified according to risk groups. DESIGN AND METHODS: From 1989 to 1994, 195 children (</abstract><cop>Pavia</cop><pub>Haematologica</pub><pmid>11418367</pmid><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0390-6078 |
| ispartof | Haematologica (Roma), 2001-06, Vol.86 (6), p.586-595 |
| issn | 0390-6078 1592-8721 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70929086 |
| source | Freely Accessible Science Journals |
| subjects | Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - standards Biological and medical sciences Chemotherapy Child Child, Preschool Drug Administration Schedule Female Humans Male Medical sciences Pharmacology. Drug treatments Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Prospective Studies Risk Factors Time Factors Treatment Outcome |
| title | Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T13%3A29%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20and%20delayed%20consolidation%20chemotherapy%20significantly%20improves%20the%20outcome%20of%20children%20with%20intermediate%20risk%20acute%20lymphoblastic%20leukemia.%20Final%20results%20of%20the%20prospective%20randomized%20PETHEMA%20ALL-89%20TRIAL&rft.jtitle=Haematologica%20(Roma)&rft.au=Ortega,%20JJ&rft.aucorp=PETHEMA%20Group,%20Spanish%20Society%20of%20Hematology.%20Programa%20para%20el%20Estudio%20y%20Tratamiento%20de%20las%20Hemopat%C3%ADas%20Malignas&rft.date=2001-06-01&rft.volume=86&rft.issue=6&rft.spage=586&rft.epage=595&rft.pages=586-595&rft.issn=0390-6078&rft.eissn=1592-8721&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E70929086%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h266t-13e79735d89bce37a4aaff5e3a372a6f41aa06425f6944317dec40302746cfbd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70929086&rft_id=info:pmid/11418367&rfr_iscdi=true |